Great Valley Advisor Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Great Valley Advisor Group's FBT Position: Q1 2026 in Review
Great Valley Advisor Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 28% in Q1 2026, buying an estimated $111K and bringing the position to 2,469 shares worth $496K. The position accounts for 0.01% of the portfolio, ranked #690.
Great Valley Advisor Group first reported a position in FBT in Q2 2020 and has held it in 20 quarters since. The position peaked at $7.06M in Q4 2023. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Great Valley Advisor Group held 2,469 shares of First Trust NYSE Arca Biotechnology Index Fund worth $496K as of Q1 2026.
- Great Valley Advisor Group bought 537 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $111K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Great Valley Advisor Group's portfolio in Q1 2026, its #690 holding.
- Great Valley Advisor Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 20 quarters since.
- Great Valley Advisor Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.06M in Q4 2023.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.